VACCINES HUMAN OR VETERINARY

Brand Owner Address Description
GENETIS THERAVECTYS 28 rue du Docteur Roux F-75015 Paris France Vaccines for human or veterinary use; vaccines for human or veterinary, therapeutic or prophylactic use, based on lentiviral vectors; chemical, biological, pharmaceutical products and preparations for therapeutic, prophylactic, medical, pharmaceutical and veterinary use; chemical reagents for therapeutic, prophylactic, medical, pharmaceutical and veterinary use; chemical-pharmaceutical products for therapeutic, prophylactic, medical, pharmaceutical and veterinary use;Scientific research and development services for medical, therapeutic, pharmaceutical, veterinary and biological purposes, in the therapeutic or prophylactic vaccination field based on lentiviruses; research and development of new biological and pharmaceutical products for therapeutic, medical and veterinary use, in the therapeutic or prophylactic vaccination field based on lentiviral vectors and immunotherapy; bacteriological research services; virology research; infectious disease research, oncology research, clinical trials of vaccines; research in the field of diagnostic and therapeutic products for the treatment of infectious diseases; research in the field of diagnostic and therapeutic products for the treatment of viral diseases and cancer;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. DNA and protein constructs useful in producing vaccines against human cytomegalovirus contain optionally N-end modified and N-terminal ubiquitinated human cytomegalovirus antigenic proteins, including pp65, pp150, IE1, gB and antigenic fragments thereof. Vaccine viruses, in particular poxviruses such as vaccinia and Modified Vaccinia Ankara, that express the constructs may be used as vaccines to augment the immune response to human cytomegalovirus, both prophylatically and in patients already carrying human cytomegalovirus, as well as to create and expand cytomegalovirus-reactive T cells for transfer of adoptive immunity.